Navigation Links
Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
Date:10/14/2009

and should consult their own investment and tax advisors.

About Par Pharmaceutical

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit www.parpharm.com.

Tender Offer Statement

This press release is for informational purposes only and is neither an offer to buy nor the solicitation of an offer to sell any securities. The full details of the tender offer, including complete instructions on how to tender the convertible notes, are included in the offer to purchase, the letter of transmittal and related materials, which are expected to be delivered to holders of Par's convertible notes shortly. Holders of convertible notes should read carefully the offer to purchase, the letter of transmittal and other related materials when they are available because they will contain important information. Holders of convertible notes may obtain free copies of the offer to purchase, the letter of transmittal and other related materials when filed with the SEC at the SEC's website at www.sec.gov. Holders may also obtain a copy of these documents, free of charge, from Georgeson Inc., the information agent for the tender offer.

Safe Harbor Statement

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward-looking and, as such, are subject to known and unknown risks, uncertainties and contingencies, many of which are beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein. Risk factors that might
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...GO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Nas...ngproductsforminimallydisruptivesurgicaltreatments...ecallonMonday,November30,2009,at5:30p.m.ET/2:30p.m...ivetoreimbursementfortheCompany,sproductsandwillin...nandanswersession.Thedial-innumbersare1-877-407-40...
(Date:11/25/2009)...GHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall/--...,aleadinginnovatorandprovideroflessinvasive,miniat...gthetreatmentofadvancedheartfailure,todayannounced...21stAnnualPiperJaffrayHealthCareConferenceat8:00am...heldattheNewYorkPalaceHotel,December1-2. ,, Ali...
(Date:11/24/2009)...N,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagnost...derofdiagnostictesting,informationandservices,anno...affrayHealthcareConferenceinNewYorkCity.Thepresent....m.EasternTime. ,, Duringtheconference,thecompa...roximate3%,operatingincometoexceed18%ofrevenues,an...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2New strategy for mending broken hearts 3F 10316 1New strategy for mending broken hearts 3F 10316 2Poor Education May Lead to Poor Health 59258 1Poor Education May Lead to Poor Health 59258 2Poor Education May Lead to Poor Health 59258 3Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 1Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 2Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 3
...S, N.J., June 20, 2007 /PRNewswire-USNewswire/ -- ...the national,non-profit organization dedicated to...ries and improving the lives of people living,with...in President,Bush,s veto of the Stem Cell Research...or advancements in stem cell research with the,sup...
...alif.--(BUSINESS WIRE)--Jun 20, 2007 - Materia, In... the licensing of its,metathesis platform to Eisai...any, for use in drug discovery and development.,Th...to discover,develop, and patent pharmaceutical co...catalysts and associated intellectual property., M...
Other Medicine Technology:The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 2The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 3Materia Licenses Metathesis Catalyst Platform to Eisai 2
(Date:11/26/2009)... No more letters from the North Pole, Textsanta.n...ages from Santa , North P...ional efficiencies at the North Pole Santa Claus h...all over the globe informed of his Christmas progr...research department have identified a large and gr...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationw...d Yasmin birth control pills who have suffered a D...oke, Heart Attack or other related cardiac issues ...oll free at 1-800-856-6405 or go to the firm&rsquo...ut an online case evaluation form. , ...
(Date:11/25/2009)...Y,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadin...ndsoftwareandCalgaryScientificInc.,aleadingprovide...versionofAegis(TM)Breast4DAdvancedVisualizationsof...yzero-footprintWebclientbasedmedicalimagingofferin...mallowsforzero-footprintaccess-requiringnosoftware...
(Date:11/25/2009)...5/PRNewswire-USNewswire/--TheBlackAIDSInstituterec...iveleadershipfor2010. ,, ThenewBoardMembersarea...policy,law,finance,governmenthealthprograms,editor...romawiderangeofpersonalbackgroundsincludingbothhet...hemselves,andrepresentingmultipleagegroups. ,, ...
(Date:11/25/2009)... evidence of a statistically significant survival ...se estrogen receptor (ER)-positive tumors had high...118 (ER-alpha S118-P), according to a brief commun...al of the National Cancer Institute . , Approxim...moxifen. Preclinical studies have shown that ER-al...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... that stents with certain drugs helps them do a be... vessels have been cleared surgically. But a new r...Researchers found that stents coated with a deriva...sulting in heart attacks in 3 cases. In angio...
...cells of oral leukoplakia, specifically the number...f oral carcinoma, according to study.// 123 patien...5 years, found that oral leukoplakia with the norm...ed cancer. However, if the number of chromoso...
... drug be injurious to health? Pharma giant GlaxoSm...essation drug, Zyban, has risen in defence of its ...eports in the UK, linking the drug to adverse reac...1. The cause for concern, however, was a safety up...
...chers, many people have believed that training wit...kept for youthful people.// According to Bruce Cra... University, men and women well past retirement ag...alls and injuries. The workouts will make you look...
...on of a tendon in the eye socket may help stop a m...n around the eye socket just before an attack star...lea tendon in the eye socket, a condition known as..., they studied five women with migraine who report...
...s, monounsaturated fats and carbohydrates can be i... offering more variety. Research done by Dr. Anura...s shown the benefits// of mono-unsaturated fats on...es experts now say that 50 to 60 per cent of calor...
Other Medicine News:
7.5mm Trephine Handle
1.0mm Trephine with Handle
8.5mm Calibrated Trephine Handle
9.0mm Calibrated Trephine Handle
Medicine Products: